Skip to main content
. Author manuscript; available in PMC: 2020 Feb 15.
Published in final edited form as: Int J Cancer. 2018 Oct 4;144(4):674–686. doi: 10.1002/ijc.31812

Figure 3: PDC reaction sequence.

Figure 3:

E1 (PDH, pyruvate dehydrogenase) first catalyzes thiamine pyrophosphate (TPP)-dependent irreversible decarboxylation of pyruvate (1) and reductive acetylation of lipoate on the lipoyl domains of E2 (and E3BP), the rate-limiting step (2). E2 (DLT, dihydrolipoyl transacetylase) then catalyzes the transfer of the acetyl group from dihydrolipoate to CoA producing Acetyl-CoA (3). E3 (DLDH, dihydrolipoyl dehydrogenase) oxidizes dihydrolipoate back to lipoate by reducing its FAD cofactor to FADH2 (4), which is oxidized back to FAD by NAD+ (5). Movement of the lipoyl domains between active sites of the individual enzymes is executed by the mobile arms of E2 and E3BP.